(Q37474904)

English

Negative regulators of T-cell activation: potential targets for therapeutic intervention in cancer, autoimmune disease, and persistent infections

scientific article published on May 2009

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

1 reference

Europe PubMed Central

Negative regulators of T-cell activation: potential targets for therapeutic intervention in cancer, autoimmune disease, and persistent infections (English)

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

autoimmune disease

1 reference

based on heuristic

inferred from title

James P. Allison

3

object named as

James P Allison

0 references

author name string

Tsvetelina Pentcheva-Hoang

1

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

Emily Corse

2

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

publication date

1 May 2009

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

Immunological Reviews

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

229

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

67-87

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

Clonal expansion versus functional clonal inactivation: a costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2009.00763.X

21 January 2018

Lymphocyte activation gene-3 (CD223) regulates the size of the expanding T cell population following antigen activation in vivo

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2009.00763.X

21 January 2018

Binding stoichiometry of the cytotoxic T lymphocyte-associated molecule-4 (CTLA-4). A disulfide-linked homodimer binds two CD86 molecules

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2009.00763.X

21 January 2018

CD86 and CD80 differentially modulate the suppressive function of human regulatory T cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2009.00763.X

21 January 2018

Structural analysis of CTLA-4 function in vivo

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2009.00763.X

21 January 2018

CTLA-4 Overexpression Inhibits T Cell Responses through a CD28-B7-Dependent Mechanism

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2009.00763.X

21 January 2018

Hierarchical regulation of CTLA-4 dimer-based lattice formation and its biological relevance for T cell inactivation.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2009.00763.X

21 January 2018

Inhibition of CTLA-4 function by the regulatory subunit of serine/threonine phosphatase 2A

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2009.00763.X

21 January 2018

B7-independent inhibition of T cells by CTLA-4.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2009.00763.X

21 January 2018

CD150 association with either the SH2-containing inositol phosphatase or the SH2-containing protein tyrosine phosphatase is regulated by the adaptor protein SH2D1A

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2009.00763.X

21 January 2018

The common gamma-chain cytokines IL-2, IL-7, IL-15, and IL-21 induce the expression of programmed death-1 and its ligands

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2009.00763.X

21 January 2018

Regulated compartmentalization of programmed cell death-1 discriminates CD4+CD25+ resting regulatory T cells from activated T cells.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2009.00763.X

21 January 2018

Expression of programmed death 1 ligands by murine T cells and APC

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2009.00763.X

21 January 2018

SHP-1 and SHP-2 associate with immunoreceptor tyrosine-based switch motif of programmed death 1 upon primary human T cell stimulation, but only receptor ligation prevents T cell activation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2009.00763.X

21 January 2018

PD-1 regulates self-reactive CD8+ T cell responses to antigen in lymph nodes and tissues

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2009.00763.X

21 January 2018

Local expression of B7-H1 promotes organ-specific autoimmunity and transplant rejection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2009.00763.X

21 January 2018

Blockade of programmed death-1 engagement accelerates graft-versus-host disease lethality by an IFN-gamma-dependent mechanism

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2009.00763.X

21 January 2018

Expression of B7-H1 on gastric epithelial cells: its potential role in regulating T cells during Helicobacter pylori infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2009.00763.X

21 January 2018

Programmed death (PD)-1:PD-ligand 1/PD-ligand 2 pathway inhibits T cell effector functions during human tuberculosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2009.00763.X

21 January 2018

Characterization of mouse and human B7-H3 genes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2009.00763.X

21 January 2018

Molecular characterization of human 4Ig-B7-H3, a member of the B7 family with four Ig-like domains.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2009.00763.X

21 January 2018

Genomic Organization and Expression Analysis of B7-H4, an Immune Inhibitory Molecule of the B7 Family

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2009.00763.X

21 January 2018

Cutting edge: induction of B7-H4 on APCs through IL-10: novel suppressive mode for regulatory T cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2009.00763.X

21 January 2018

B7-H3 enhances tumor immunity in vivo by costimulating rapid clonal expansion of antigen-specific CD8+ cytolytic T cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2009.00763.X

21 January 2018

An inhibitory Ig superfamily protein expressed by lymphocytes and APCs is also an early marker of thymocyte positive selection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2009.00763.X

21 January 2018

Structural determinants of herpesvirus entry mediator recognition by murine B and T lymphocyte attenuator

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2009.00763.X

21 January 2018

The role of herpesvirus entry mediator as a negative regulator of T cell-mediated responses

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2009.00763.X

21 January 2018

B and T lymphocyte attenuator exhibits structural and expression polymorphisms and is highly Induced in anergic CD4+ T cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2009.00763.X

21 January 2018

Reciprocal expression of the TNF family receptor herpes virus entry mediator and its ligand LIGHT on activated T cells: LIGHT down-regulates its own receptor

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2009.00763.X

21 January 2018

Cutting edge: B and T lymphocyte attenuator and programmed death receptor-1 inhibitory receptors are required for termination of acute allergic airway inflammation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2009.00763.X

21 January 2018

Differential effects of B and T lymphocyte attenuator and programmed death-1 on acceptance of partially versus fully MHC-mismatched cardiac allografts.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2009.00763.X

21 January 2018

Regulatory T cell expression of herpesvirus entry mediator suppresses the function of B and T lymphocyte attenuator-positive effector T cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2009.00763.X

21 January 2018

B and T lymphocyte attenuator regulates T cell survival in the lung

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2009.00763.X

21 January 2018

Cutting edge: molecular analysis of the negative regulatory function of lymphocyte activation gene-3

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2009.00763.X

21 January 2018

CTLA-4 can function as a negative regulator of T cell activation

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1016/1074-7613(94)90071-X

Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1002/J.1460-2075.1992.TB05481.X

Abatacept: a novel treatment for moderate-to-severe rheumatoid arthritis

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Engagement of B7 on effector T cells by regulatory T cells prevents autoimmune disease

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Crystal structure of the complex between programmed death-1 (PD-1) and its ligand PD-L2

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Association of Grb-2 and PI3K p85 with phosphotyrosile peptides derived from BTLA.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Structure, expression, and T cell costimulatory activity of the murine homologue of the human B lymphocyte activation antigen B7

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

B7-H3 ligand expression by prostate cancer: a novel marker of prognosis and potential target for therapy

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Expression of LAG-3 by tumor-infiltrating lymphocytes is coincident with the suppression of latent membrane antigen-specific CD8+ T-cell function in Hodgkin lymphoma patients.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

B7-H3: a costimulatory molecule for T cell activation and IFN-gamma production

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Interaction of human PD-L1 and B7-1.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Expression and functional significance of an additional ligand for CTLA-4.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Tumor B7-H1 is associated with poor prognosis in renal cell carcinoma patients with long-term follow-up.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Solution structure of human CTLA-4 and delineation of a CD80/CD86 binding site conserved in CD28

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Immunosuppression in vivo by a soluble form of the CTLA-4 T cell activation molecule

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Negative regulation of T cell receptor-lipid raft interaction by cytotoxic T lymphocyte-associated antigen 4.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Structural and functional analysis of the costimulatory receptor programmed death-1.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4lg

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Regulatory T cells inhibit stable contacts between CD4+ T cells and dendritic cells in vivo

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Differential role of programmed death-ligand 1 [corrected] and programmed death-ligand 2 [corrected] in regulating the susceptibility and chronic progression of experimental autoimmune encephalomyelitis

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

PD-L2 is a second ligand for PD-1 and inhibits T cell activation

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

T-cell co-stimulation through B7RP-1 and ICOS

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

B7-1 or B7-2 is required to produce the lymphoproliferative phenotype in mice lacking cytotoxic T lymphocyte-associated antigen 4 (CTLA-4)

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Negative and positive co-signaling with anti-BTLA (PJ196) and CTLA4Ig prolongs islet allograft survival

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Comment on "Cutting edge: induction of B7-H4 on APCs through IL-10: novel suppressive mode for regulatory T cells"

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

B7-H3 and B7-H4 expression in non-small-cell lung cancer

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

CTLA-4 disrupts ZAP70 microcluster formation with reduced T cell/APC dwell times and calcium mobilization

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Erratum: Costimulation and endogenous MHC ligands contribute to T cell recognition

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

The CD28 and CTLA-4 receptors associate with the serine/threonine phosphatase PP2A.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

CTLA-4 blockade synergizes with tumor-derived granulocyte-macrophage colony-stimulating factor for treatment of an experimental mammary carcinoma.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Immunohistochemical localization of programmed death-1 ligand-1 (PD-L1) in gastric carcinoma and its clinical significance

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Cytotoxic T lymphocyte antigen 4 and CD28 modulate cell surface raft expression in their regulation of T cell function

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Molecular basis of T cell inactivation by CTLA-4

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

CTLA-4 blockade reverses CD8+ T cell tolerance to tumor by a CD4+ T cell- and IL-2-dependent mechanism

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Role of LAG-3 in regulatory T cells.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

T lymphocyte costimulation mediated by reorganization of membrane microdomains

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Aberrant regulation of synovial T cell activation by soluble costimulatory molecules in rheumatoid arthritis

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

An autoimmune disease-associated CTLA-4 splice variant lacking the B7 binding domain signals negatively in T cells

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Tissue expression of PD-L1 mediates peripheral T cell tolerance.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Programmed death-1 concentration at the immunological synapse is determined by ligand affinity and availability

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

PD-1 inhibits T-cell receptor induced phosphorylation of the ZAP70/CD3zeta signalosome and downstream signaling to PKCtheta

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

B7-H1 determines accumulation and deletion of intrahepatic CD8(+) T lymphocytes.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

CD4/major histocompatibility complex class II interaction analyzed with CD4‐ and lymphocyte activation gene‐3 (LAG‐3)‐Ig fusion proteins

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Cytotoxic T lymphocyte antigen 4 (CTLA4) blockade accelerates the acute rejection of cardiac allografts in CD28-deficient mice: CTLA4 can function independently of CD28.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Combined coinhibitory and costimulatory modulation with anti-BTLA and CTLA4Ig facilitates tolerance in murine islet allografts

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Mast cells enhance T cell activation: importance of mast cell costimulatory molecules and secreted TNF

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Insulin-induced remission in new-onset NOD mice is maintained by the PD-1-PD-L1 pathway.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Prevention of allogeneic fetal rejection by tryptophan catabolism

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Membrane compartmentation is required for efficient T cell activation.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

B7-H1 (CD274) inhibits the development of herpetic stromal keratitis (HSK).

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Expression of lymphocyte activation gene 3 (LAG-3) on B cells is induced by T cells

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Crystal structure of the receptor-binding domain of human B7-2: Insights into organization and signaling

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

The B7 family member B7-H3 preferentially down-regulates T helper type 1-mediated immune responses

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

CTLA-4-Ig regulates tryptophan catabolism in vivo.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

PD-1 Expression in Acute Hepatitis C Virus (HCV) Infection Is Associated with HCV-Specific CD8 Exhaustion

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

LAG-3 regulates CD8+ T cell accumulation and effector function in murine self- and tumor-tolerance systems

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Different cell surface oligomeric states of B7-1 and B7-2: implications for signaling

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Structure and dimerization of a soluble form of B7-1

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

The PD-1/PD-L1 complex resembles the antigen-binding Fv domains of antibodies and T cell receptors

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Manipulation of T cell costimulatory and inhibitory signals for immunotherapy of prostate cancer

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

The tissue distribution of the B7-2 costimulator in mice: abundant expression on dendritic cells in situ and during maturation in vitro

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

CTLA-4 (CD152) can inhibit T cell activation by two different mechanisms depending on its level of cell surface expression

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Establishment of NOD-Pdcd1-/- mice as an efficient animal model of type I diabetes

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

B7-H1 costimulation preferentially enhances CD28-independent T-helper cell function

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Co-inhibitory role of T-cell-associated B7-H1 and B7-DC in the T-cell immune response.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Regulation of lymphokine messenger RNA stability by a surface-mediated T cell activation pathway

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Visualizing regulatory T cell control of autoimmune responses in nonobese diabetic mice

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

B7-H4, a molecule of the B7 family, negatively regulates T cell immunity

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

B and T lymphocyte attenuator-mediated signal transduction provides a potent inhibitory signal to primary human CD4 T cells that can be initiated by multiple phosphotyrosine motifs

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Involvement of programmed death-ligand 2 (PD-L2) in the development of experimental allergic conjunctivitis in mice

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Tumor cell and tumor vasculature expression of B7-H3 predict survival in clear cell renal cell carcinoma

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Analysis of the role of negative T cell costimulatory pathways in CD4 and CD8 T cell-mediated alloimmune responses in vivo

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

In vivo costimulatory role of B7-DC in tuning T helper cell 1 and cytotoxic T lymphocyte responses

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

T cell receptor-interacting molecule acts as a chaperone to modulate surface expression of the CTLA-4 coreceptor.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Targeting lymphocyte activation through the lymphotoxin and LIGHT pathways

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

The negative regulatory function of the lymphocyte-activation gene-3 co-receptor (CD223) on human T cells

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Cytotoxic T lymphocyte-associated molecule-4, a high-avidity receptor for CD80 and CD86, contains an intracellular localization motif in its cytoplasmic tail

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

A new member of the immunoglobulin superfamily--CTLA-4

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

B7DC/PDL2 promotes tumor immunity by a PD-1-independent mechanism.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Cytotoxic T lymphocyte antigen-4 accumulation in the immunological synapse is regulated by TCR signal strength

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Combination immunotherapy of B16 melanoma using anti-cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) and granulocyte/macrophage colony-stimulating factor (GM-CSF)-producing vaccines induces rejection of subcutaneous and metastatic tumors accomp

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Surface cytotoxic T lymphocyte-associated antigen 4 partitions within lipid rafts and relocates to the immunological synapse under conditions of inhibition of T cell activation

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Identification of 4Ig-B7-H3 as a neuroblastoma-associated molecule that exerts a protective role from an NK cell-mediated lysis

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Development of autoimmune hepatitis-like disease and production of autoantibodies to nuclear antigens in mice lacking B and T lymphocyte attenuator

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

B and T lymphocyte attenuator regulates T cell activation through interaction with herpesvirus entry mediator

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Structure and chromosomal localization of the human PD-1 gene (PDCD1)

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Distinct roles of CTLA-4 and TGF-beta in CD4+CD25+ regulatory T cell function

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Characterization of phosphotyrosine binding motifs in the cytoplasmic domain of B and T lymphocyte attenuator required for association with protein tyrosine phosphatases SHP-1 and SHP-2.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Differential expression of PD-L1 and PD-L2, ligands for an inhibitory receptor PD-1, in the cells of lymphohematopoietic tissues.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Treatment of murine lupus with CTLA4Ig

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Cloning of B7-2: a CTLA-4 Counter-Receptor That Costimulates Human T Cell Proliferation

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

A critical role for the programmed death ligand 1 in fetomaternal tolerance

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Triggering receptor expressed on myeloid cell-like transcript 2 (TLT-2) is a counter-receptor for B7-H3 and enhances T cell responses

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

PD-L1 and PD-L2 are differentially regulated by Th1 and Th2 cells

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Interaction of CTLA-4 with AP50, a clathrin-coated pit adaptor protein

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Independent modes of natural killing distinguished in mice lacking Lag3

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

B7-1 and B7-2 have overlapping, critical roles in immunoglobulin class switching and germinal center formation

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

B7x: a widely expressed B7 family member that inhibits T cell activation

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-XL.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Paradoxical role of programmed death-1 ligand 2 in Th2 immune responses in vitro and in a mouse asthma model in vivo

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

B7-H1 expression on non-small cell lung cancer cells and its relationship with tumor-infiltrating lymphocytes and their PD-1 expression

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Uncovering of Functional Alternative CTLA-4 Counter-Receptor in B7-Deficient Mice

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

B7S1, a novel B7 family member that negatively regulates T cell activation

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

B7-H1 is a ubiquitous antiapoptotic receptor on cancer cells

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Identification of an Alternative CTLA-4 Ligand Costimulatory for T Cell Activation

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

In vivo blockade of CTLA-4 enhances the priming of responsive T cells but fails to prevent the induction of tumor antigen-specific tolerance.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Modulation of tryptophan catabolism by regulatory T cells.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Phase I safety and pharmacokinetic study of CT-011, a humanized antibody interacting with PD-1, in patients with advanced hematologic malignancies

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

PD-1/PD-L1, but not PD-1/PD-L2, interactions regulate the severity of experimental autoimmune encephalomyelitis

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

T Lymphocytes infiltrating various tumour types express the MHC class II ligand lymphocyte activation gene-3 (LAG-3): role of LAG-3/MHC class II interactions in cell-cell contacts

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

B7-H3 and B7x are highly expressed in human prostate cancer and associated with disease spread and poor outcome

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Intracellular trafficking of CTLA-4 and focal localization towards sites of TCR engagement

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

B7-DC regulates asthmatic response by an IFN-gamma-dependent mechanism

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Murine B7-2, an alternative CTLA4 counter-receptor that costimulates T cell proliferation and interleukin 2 production

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

The interaction properties of costimulatory molecules revisited.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Role of the programmed death-1 pathway in regulation of alloimmune responses in vivo

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Cell intrinsic mechanisms of T-cell inhibition and application to cancer therapy

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

CTLA-4 control over Foxp3+ regulatory T cell function

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

A soluble form of CTLA-4 generated by alternative splicing is expressed by nonstimulated human T cells

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Duplication of primate and rodent B7-H3 immunoglobulin V- and C-like domains: divergent history of functional redundancy and exon loss

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Regulation of T cell receptor signaling by tyrosine phosphatase SYP association with CTLA-4

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Dysfunction and functional restoration of HCV-specific CD8 responses in chronic hepatitis C virus infection

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

PD-L1 (B7-H1) expression by urothelial carcinoma of the bladder and BCG-induced granulomata: associations with localized stage progression.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Clinical significance and therapeutic potential of the programmed death-1 ligand/programmed death-1 pathway in human pancreatic cancer.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Overexpression of B7-H1 (PD-L1) significantly associates with tumor grade and postoperative prognosis in human urothelial cancers

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

B7-1 and B7-2 selectively recruit CTLA-4 and CD28 to the immunological synapse

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Human Ig superfamily CTLA-4 gene: chromosomal localization and identity of protein sequence between murine and human CTLA-4 cytoplasmic domains

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Tyrosine phosphorylation controls internalization of CTLA-4 by regulating its interaction with clathrin-associated adaptor complex AP-2

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Reversal of the TCR stop signal by CTLA-4

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Generation and characterization of B7-H4/B7S1/B7x-deficient mice

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Structural basis for co-stimulation by the human CTLA-4/B7-2 complex

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

The three HveA receptor ligands, gD, LT-alpha and LIGHT bind to distinct sites on HveA.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

CD160 inhibits activation of human CD4+ T cells through interaction with herpesvirus entry mediator

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Phenotypic analysis of the murine CD4-related glycoprotein, CD223 (LAG-3).

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Crystal structure of the B7-1/CTLA-4 complex that inhibits human immune responses

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

CTLA-4 ligation blocks CD28-dependent T cell activation

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Structure of murine CTLA-4 and its role in modulating T cell responsiveness

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Regulation of PD‐1, PD‐L1, and PD‐L2 expression during normal and autoimmune responses

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Functional analysis of B and T lymphocyte attenuator engagement on CD4+ and CD8+ T cells

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

B7h, a novel costimulatory homolog of B7.1 and B7.2, is induced by TNFalpha

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

A native soluble form of CTLA-4

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Regulation of T cell activation and tolerance by PDL2

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Independent CD28 signaling via VAV and SLP-76: a model for in trans costimulation

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

LAG-3, a novel lymphocyte activation gene closely related to CD4

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Serum-soluble B7x is elevated in renal cell carcinoma patients and is associated with advanced stage

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Autoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PD-1-deficient mice

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

CTLA4 blockade and GM-CSF combination immunotherapy alters the intratumor balance of effector and regulatory T cells

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Liver-Infiltrating Lymphocytes in Chronic Human Hepatitis C Virus Infection Display an Exhausted Phenotype with High Levels of PD-1 and Low Levels of CD127 Expression

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Attenuating lymphocyte activity: the crystal structure of the BTLA-HVEM complex

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Limited tumor infiltration by activated T effector cells restricts the therapeutic activity of regulatory T cell depletion against established melanoma

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Blockade of CTLA-4 on CD4+CD25+ regulatory T cells abrogates their function in vivo

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

A coreceptor interaction between the CD28 and TNF receptor family members B and T lymphocyte attenuator and herpesvirus entry mediator

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

PD-L2 expression extends beyond dendritic cells/macrophages to B1 cells enriched for V(H)11/V(H)12 and phosphatidylcholine binding.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Blockade of B7-H1 improves myeloid dendritic cell–mediated antitumor immunity

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Restoring function in exhausted CD8 T cells during chronic viral infection

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

CTLA-4 is a second receptor for the B cell activation antigen B7

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Thymocyte development is normal in CTLA-4-deficient mice

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

B7-1 engagement of cytotoxic T lymphocyte antigen 4 inhibits T cell activation in the absence of CD28.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

PD-L1-deficient mice show that PD-L1 on T cells, antigen-presenting cells, and host tissues negatively regulates T cells

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Balancing co-stimulation and inhibition with BTLA and HVEM.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Blocking of monocyte-associated B7-H1 (CD274) enhances HCV-specific T cell immunity in chronic hepatitis C infection

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

B7-H4 expression in renal cell carcinoma and tumor vasculature: associations with cancer progression and survival

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Androgen ablation mitigates tolerance to a prostate/prostate cancer-restricted antigen

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

B7-h4 is highly expressed in ductal and lobular breast cancer

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Costimulatory molecule B7-H1 in primary and metastatic clear cell renal cell carcinoma

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Comparative analysis of B7-1 and B7-2 costimulatory ligands: expression and function

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

The CD4-related molecule, LAG-3 (CD223), regulates the expansion of activated T cells

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Enhancement of antitumor immunity by CTLA-4 blockade

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Alternative splice variants of the human PD-1 gene

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

A crucial role for HVEM and BTLA in preventing intestinal inflammation

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Critical role of the programmed death-1 (PD-1) pathway in regulation of experimental autoimmune encephalomyelitis

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Cross-regulation between herpesviruses and the TNF superfamily members

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

B7-H4 Is a Novel Membrane-Bound Protein and a Candidate Serum and Tissue Biomarker for Ovarian Cancer

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Recognition of the peripheral self by naturally arising CD25+ CD4+ T cell receptors

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

B and T lymphocyte attenuator regulates CD8+ T cell-intrinsic homeostasis and memory cell generation

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

PD-1 is a regulator of virus-specific CD8+ T cell survival in HIV infection

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Negative regulation of T cell homeostasis by lymphocyte activation gene-3 (CD223)

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Programmed cell death 1 ligand 1 and tumor-infiltrating CD8+ T lymphocytes are prognostic factors of human ovarian cancer

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

T cell major histocompatibility complex class II molecules down-regulate CD4+ T cell clone responses following LAG-3 binding

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2009.00763.X

Identifiers

10.1111/J.1600-065X.2009.00763.X

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37474904&oldid=2175944573"